# PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study

Study · id `cardio:ct-nct01997112` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01997112](<https://clinicaltrials.gov/study/NCT01997112>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01997112

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01997112. Randomized; quadruple masking; primary purpose supportive care. Start 2014-01 (registry gives no type); primary completion 2019-06-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01997112, source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT01997112, source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)
- Primary completion: 2019-06-04 (actual) (ClinicalTrials.gov record NCT01997112, source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)
- Completion: 2019-10 (actual) (ClinicalTrials.gov record NCT01997112, source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01997112, source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01997112-2019-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
- Acronym: PATH-BP
- Condition: Blood Pressure
- Intervention (Drug): Paracetamol
- Intervention (Drug): Placebo oral capsule
- Lead sponsor: University of Edinburgh
- Lead sponsor class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER
- Collaborator: National Health Service, United Kingdom
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)

## Provenance

Content hash: 84d0f67b90e3c1be1aba2d895dd33f63e9b059639c5e8d8c24d40ef827fc14f5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
